BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23148506)

  • 1. The photon-isoeffective dose in boron neutron capture therapy.
    González SJ; Santa Cruz GA
    Radiat Res; 2012 Dec; 178(6):609-21. PubMed ID: 23148506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEPTH DISTRIBUTIONS OF RBE-WEIGHTED DOSE and PHOTON-ISOEFFECTIVE DOSE FOR BORON NEUTRON CAPTURE THERAPY.
    Sato T; Masunaga SI; Kumada H; Hamada N
    Radiat Prot Dosimetry; 2019 May; 183(1-2):247-250. PubMed ID: 30535354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response.
    Hiratsuka J; Fukuda H; Kobayashi T; Kanda K; Honda C; Ichihashi M; Mishima Y
    Radiat Med; 1996; 14(5):257-63. PubMed ID: 8988505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Photon Isoeffective Dose Models Based on In Vitro and In Vivo Radiobiological Experiments for Head and Neck Cancer Treated with BNCT.
    Perotti Bernardini GF; Bortolussi S; Koivunoro H; Provenzano L; Ferrari C; Cansolino L; Postuma I; Carando DG; Kankaanranta L; Joensuu H; González SJ
    Radiat Res; 2022 Aug; 198(2):134-144. PubMed ID: 35504003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photon iso-effective dose for cancer treatment with mixed field radiation based on dose-response assessment from human and an animal model: clinical application to boron neutron capture therapy for head and neck cancer.
    González SJ; Pozzi ECC; Monti Hughes A; Provenzano L; Koivunoro H; Carando DG; Thorp SI; Casal MR; Bortolussi S; Trivillin VA; Garabalino MA; Curotto P; Heber EM; Santa Cruz GA; Kankaanranta L; Joensuu H; Schwint AE
    Phys Med Biol; 2017 Oct; 62(20):7938-7958. PubMed ID: 28858854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
    Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
    Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantage and limitations of weighting factors and weighted dose quantities and their units in boron neutron capture therapy.
    Rassow J; Sauerwein W; Wittig A; Bourhis-Martin E; Hideghéty K; Moss R
    Med Phys; 2004 May; 31(5):1128-34. PubMed ID: 15191301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor.
    Fukuda H; Hiratsuka J; Kobayashi T; Sakurai Y; Yoshino K; Karashima H; Turu K; Araki K; Mishima Y; Ichihashi M
    Australas Phys Eng Sci Med; 2003 Sep; 26(3):97-103. PubMed ID: 14626847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter.
    Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of single-dose and fractionated boron neutron capture therapy.
    Coderre JA; Morris GM; Micca PL; Fisher CD; Ross GA
    Radiat Res; 1995 Dec; 144(3):310-7. PubMed ID: 7494875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines.
    Rossini AE; Dagrosa MA; Portu A; Saint Martin G; Thorp S; Casal M; Navarro A; Juvenal GJ; Pisarev MA
    Int J Radiat Biol; 2015 Jan; 91(1):81-9. PubMed ID: 25004948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoeffective dose: a concept for biological weighting of absorbed dose in proton and heavier-ion therapies.
    Wambersie A; Menzel HG; Andreo P; DeLuca PM; Gahbauer R; Hendry JH; Jones DT
    Radiat Prot Dosimetry; 2011 Feb; 143(2-4):481-6. PubMed ID: 21138926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric evaluation of neutron capture therapy for local advanced breast cancer.
    Yanagie H; Kumada H; Sakurai Y; Nakamura T; Furuya Y; Sugiyama H; Ono K; Takamoto S; Eriguchi M; Takahashi H
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S63-6. PubMed ID: 19427224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour.
    Postuma I; Magni C; Marcaccio B; Fatemi S; Vercesi V; Ciocca M; Magro G; Orlandi E; Vischioni B; Ronchi S; Liu YH; Han Y; Geng C; González SJ; Bortolussi S
    Sci Rep; 2024 Jan; 14(1):418. PubMed ID: 38172585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.
    Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1584-9. PubMed ID: 17056195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron capture therapy for murine malignant gliomas.
    Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
    Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
    Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.